openPR Logo
Press release

The Global Clinical Trial Imaging Market is likely to climb to USD 2.1 billion by 2031 - ICON plc, BioTelemetry Inc, Biomedical Systems Corporation, Medpace Holdings, Inc

05-11-2023 05:31 PM CET | Health & Medicine

Press release from: Global Insight Services

Clinical Trial Imaging Market

Clinical Trial Imaging Market

The global clinical trial imaging market was valued at USD 1.2 billion in 2021 and it is anticipated to grow at 5.9% CAGR during the forecast period to reach up to USD 2.1 billion by 2031.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10256

Clinical Trial Imaging comprises the use of imaging modalities, analysis services, and software to effectively determine the efficacy of novel medications prior to commercial release. Clinical Imaging techniques are increasingly used in oncology drug clinical trials to provide evidence for the drug's effectiveness and safety.

The imaging systems commonly used in clinical trials comprise Positron Emission Tomography (PET), Optical Coherence Tomography (OCT), Magnetic Resonance Imaging (MRI), and Ultrasound.

Read More Report of Clinical Trial Imaging Market: https://www.globalinsightservices.com/reports/clinical-trial-imaging-market/

The growth in the number of cancer diagnoses and deaths worldwide is estimated to drive the market during the projection period. However, the stringent government regulations in the sector are projected to restrict growth opportunities for the Clinical Trial Imaging Industry.

Market Trends and Drivers

The key factor such as an increase in R&D spending is an increase in R&D spending. Pharmaceutical and biotechnology companies invest heavily in research to develop breakthrough molecules. Growth in the R&D expenditure by pharmaceutical & biotechnology companies and governments combined with the increasing focus on life science projects to develop new therapeutic & diagnostic products is estimated to boost the clinical trial imaging market. Likewise, developing countries such as India, South Korea, Brazil, and Mexico offer significant growth opportunities to players operating in the clinical trial imaging market, mainly owing to the growing R&D funding in these countries.

These developing markets also have a strong trend of commercialization of life science research. With significant developments in life sciences research, these economies are anticipated to offer high growth opportunities in the clinical trial imaging market. Moreover, Asian markets, especially China and India, have many CROs that offer drug discovery services to pharmaceutical and biotechnology companies. With the significant increase in R&D funding and CROs operating in emerging countries, the demand for clinical trial imaging is anticipated to boost in these countries in the upcoming years.

Get A Customized Scope to Match, Your Need Ask an Expert - https://www.globalinsightservices.com/request-customization/GIS10256

Market Segments

By Products & Services

Services
Software
By Modality

Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-ray
Echocardiography
By Therapeutic Area

Oncology
Infectious Diseases
Neurology
CVS
Endocrinology
Immunological Disorder
By End User

Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturer
Contract Research Organizations
Academic & Government Research Institutes

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/checkout/single_user/GIS10256

Major Players in Global Clinical Trial Imaging Market

The key players in the global clinical trial imaging market are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace Klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US).

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail:info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Clinical Trial Imaging Market is likely to climb to USD 2.1 billion by 2031 - ICON plc, BioTelemetry Inc, Biomedical Systems Corporation, Medpace Holdings, Inc here

News-ID: 3050756 • Views:

More Releases from Global Insight Services

Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4% Cagr. Key Players: Sustainalytics, Reprisk, Arabesque.
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4 …
Market Overview ESG Risk Management Market is gaining significant momentum as businesses increasingly prioritize sustainability and ethical governance in their operations. Valued at $268.8 million in 2024, the market is projected to surge to $1,032.2 million by 2034, growing at a CAGR of 14.4%. The ESG Risk Management Market encompasses technologies and services designed to identify, monitor, and mitigate environmental, social, and governance risks, ensuring businesses operate responsibly while complying with
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4% Cagr. Key Players: Sonicwall, Watchguard, Palo Alto Networks.
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4 …
Market Overview Enterprise Firewall Market is witnessing substantial growth as organizations worldwide prioritize safeguarding their digital infrastructure from sophisticated cyber threats. Valued at $15 billion in 2024, the market is projected to reach $40.3 billion by 2034, expanding at a CAGR of 10.4%. The Enterprise Firewall Market encompasses solutions designed to secure enterprise networks by monitoring, filtering, and blocking unauthorized access while ensuring uninterrupted business operations. With the surge in cyberattacks,

All 5 Releases


More Releases for Imaging

Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound. The mobile gamma camera types include single, dual and
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market. Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years. Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry